Abeona Therapeutics, Inc. (ABEO)
5.41
+0.05
(+0.93%)
USD |
NASDAQ |
Jun 11, 12:18
Abeona Therapeutics Total Assets (Quarterly) : 198.49M for March 31, 2026
Total Assets (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Total Assets (Quarterly) Data
| Date | Value |
|---|---|
| March 31, 2026 | 198.49M |
| December 31, 2025 | 221.17M |
| September 30, 2025 | 231.10M |
| June 30, 2025 | 246.23M |
| March 31, 2025 | 99.36M |
| December 31, 2024 | 108.93M |
| September 30, 2024 | 120.59M |
| June 30, 2024 | 134.00M |
| March 31, 2024 | 74.83M |
| December 31, 2023 | 64.00M |
| September 30, 2023 | 66.09M |
| June 30, 2023 | 53.55M |
| March 31, 2023 | 53.34M |
| December 31, 2022 | 64.21M |
| September 30, 2022 | 38.76M |
| June 30, 2022 | 44.72M |
| March 31, 2022 | 55.17M |
| December 31, 2021 | 79.59M |
| September 30, 2021 | 119.02M |
| June 30, 2021 | 130.68M |
| March 31, 2021 | 141.43M |
| December 31, 2020 | 151.20M |
| September 30, 2020 | 159.36M |
| June 30, 2020 | 164.38M |
| March 31, 2020 | 175.00M |
| Date | Value |
|---|---|
| December 31, 2019 | 223.38M |
| September 30, 2019 | 142.77M |
| June 30, 2019 | 159.41M |
| March 31, 2019 | 166.14M |
| December 31, 2018 | |
| September 30, 2018 | 160.58M |
| June 30, 2018 | 166.70M |
| March 31, 2018 | 175.65M |
| December 31, 2017 | 178.77M |
| September 30, 2017 | 95.73M |
| June 30, 2017 | 96.66M |
| March 31, 2017 | 105.28M |
| December 31, 2016 | 111.06M |
| September 30, 2016 | 73.81M |
| June 30, 2016 | 74.15M |
| March 31, 2016 | 77.42M |
| December 31, 2015 | 80.06M |
| September 30, 2015 | 89.55M |
| June 30, 2015 | 76.92M |
| March 31, 2015 | 13.12M |
| December 31, 2014 | 16.58M |
| September 30, 2014 | 0.28M |
| June 30, 2014 | 0.24M |
| March 31, 2014 | 0.478M |
| December 31, 2013 | 0.613M |
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Assets (Quarterly) Benchmarks
| Corcept Therapeutics, Inc. | 814.88M |
| Forum Markets, Inc. | 207.61M |
| Precigen, Inc. | 138.63M |
| PDS Biotechnology Corp. | 24.66M |
| ACADIA Pharmaceuticals, Inc. | 1.605B |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 53.56M |
| Shareholders Equity (Quarterly) | 144.94M |
| Debt to Equity Ratio | 0.1599 |
| Current Ratio | 5.894 |
| Net Debt Paydown Yield | -0.01% |